Monday, May 16, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Chinese pharma companies to produce version of Pfizer’s vaccine

China, Covid-19, Pfizer, medicamento, convenio

Chinese pharma companies to produce version of Pfizer’s vaccine

Beijing, Mar 18 (Prensa Latina) Five Chinese pharma companies have signed an agreement with a UN-backed organization to produce a generic version of Pfizer's antiviral Nirmatrelvir, used to treat Covid-19 patients, local press reported on Friday.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to Global Times, the five pharmaceutical companies are Zhejiang Huahai Pharmaceutical Co, Apeloa Pharmaceutical, Fosun Pharma, Zhejiang Jiuzhou Pharmaceutical Co and Shanghai Desano Pharmaceuticals Co. They sealed the agreement with Medicines Patent Pool.

Of the five companies, Zhejiang Jiuzhou Pharmaceutical Co will focus on producing the drug substance and the other four will produce the finished product.

The medicine will be supplied in 95 low- and middle-income nations, comprising 53 percent of the world’s population.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.